Delivery Order SPE2DB22D3501-SPE2DB24FVQ38

Award Date 5/10/24
Potential Completion Date 5/13/24
Potential Value $2.9K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $1,916.30 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, Corporate Office division, for the supply of 4,565,131,555 units of 5 mg methylphenidate chewable tablets. This order is part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which enables DLA to efficiently procure a range of pharmaceutical products and medical supplies to support military treatment programs...
The federal contract award summarized here is a delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA). The $1,305.00 firm fixed price contract is for the supply of 4,564,450,168 tablets of Methylphenidate ER 27 mg, with a completion date of May 1, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical that serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,414.34, is a delivery order for the provision of 4,566,477,023 tablets of Methylphenidate ER 36 mg. The contract has an ultimate completion date of November 19, 2024. It is a firm fixed-price contract with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,232.09 Firm Fixed Price delivery order is for the supply of 4,564,588,975 units of Methylphenidate ER 54 mg tablets. The contract has an ultimate completion date of May 14, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through...
The U.S. Department of Defense's Medical Supply Chain (DLA Troop Support Medical) awarded a delivery order contract worth $1,510.65 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of methylphenidate ER 18 mg tablets in 100-count packages. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the Defense Logistics Agency, valued up to $999,999,999.00 through December 2025, to provide a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $1,305.00 firm fixed price delivery order is for the supply of 4,564,090,484 units of Methylphenidate ER 27 mg tablets to support military treatment programs. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $1,009.01 firm fixed price delivery order is for the supply of 4,564,514,419 methylphenidate extended-release 18 mg tablets. The award was made without any set-aside designations. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The award, valued at $1,028.17, is for the delivery of 4,564,339,501 Methylphenidate ER 27 mg tablets in 100-count bottles. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of April 22, 2024. Amerisourcebergen also holds a larger...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,380.64 Firm Fixed Price Delivery Order is for the medication Methylphenidate ER 54 mg tablets. The contract has an ultimate completion date of November 13, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply Methylphenidate ER 36 mg tablets. The $2,167.09 firm fixed price delivery order has an ultimate completion date of March 29, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FVQ38
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The $2,897.42 fixed-price delivery order is for the supply of 4,564,572,472 tablets of Methylphenidate ER 36 mg.

Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

The contract does not have a set-aside designation. Amerisourcebergen's extensive expertise and supply chain capabilities in the pharmaceutical distribution industry allow it to competitively fulfill these types of government contracts to support the medical needs of U.S. military and federal agencies.

Generated 8/9/24, 9:26 AM